Project Grant R03CA313287
Award Date 6/1/26
Completion Date 5/31/28
Dollars Obligated $157K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48824, USA
Similar Awards
- Federal Grant Award Summary Michigan State University (through its Henry Ford Health+Michigan State University Health Sciences partnership) received a $153,278 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) effective July 3, 2025, with completion expected June 30, 2027. The award supports the development of a Dre-Rox recombination-based Genetically Engineered Mouse Model (GEMM) for NUT carcinoma, a rare but aggressive...
- Federal Project Grant Award Summary The University of Michigan received a $646,881 Project Grant award from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), effective April 1, 2026 through March 31, 2031. The award supports research focused on developing and validating ASH1L (Absent, Small or Homeotic 1-Like) histone methyltransferase inhibitors as a novel therapeutic approach for acute leukemia treatment. The research addresses a critical clinical...
- Federal Project Grant Award Summary Northern Michigan University received a $462,153 Project Grant award from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396) on September 4, 2025, with a completion date of August 31, 2026. The award supports the development and application of D2HGLO, a novel genetically encoded fluorescent biosensor tool designed to detect and quantify the oncometabolite D-2-hydroxyglutarate (D-2-HG) in intact cells. This biosensor addresses...
- Federal Grant Award Summary The National Cancer Institute awarded $138,846 to the University Health Network under the Cancer Detection and Diagnosis Research program (CFDA 93.394) for a two-year Project Grant commencing August 1, 2025 and concluding July 31, 2027. The award supports the development of laboratory-generated "wild-like" mouse models designed to enhance the translational relevance of preclinical cancer and immunotherapy research. The primary deliverable involves adapting...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the Regents of the University of Michigan $175,448 under the Cancer Research Manpower program (CFDA 93.398) on January 16, 2026, with completion targeted for July 31, 2027. This project grant supports research training and investigator development in cancer biology, specifically focused on characterizing cancer-associated fibroblasts (CAFs) and their role in pancreatic ductal adenocarcinoma (PDAC). The research aims to...
- Federal Grant Award Summary The National Cancer Institute awarded the Regents of the University of Michigan a $640,135 Project Grant under the Cancer Treatment Research program (CFDA 93.395) effective August 1, 2025 through July 31, 2030. This award supports the development of next-generation menin inhibitors designed to overcome clinical resistance observed in acute myeloid leukemia (AML) patients undergoing menin inhibitor therapy. The research addresses the critical clinical problem of...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant of $136,412 to the Regents of the University of Michigan, effective August 1, 2025 through July 31, 2027, under the Cancer Research Manpower program (CFDA 93.398). This award funds research aimed at defining and interrupting metabolic crosstalk in the glioblastoma microenvironment. The research builds upon preliminary findings demonstrating that glioblastoma (GBM) tumors acquire nutrients through...
- Federal Project Grant Award Summary The National Cancer Institute awarded a Project Grant of $152,586 to the University of Michigan (Regents of the University of Michigan, Office of Research and Sponsored Projects Division) under the Cancer Research Manpower program (CFDA 93.398) on December 12, 2025, with a completion date of June 16, 2028. This award supports biomedical research training and scientific investigation into MS4A14 (Membrane-Spanning 4A member 14), a macrophage-expressed protein...
- Federal Project Grant Award Summary The National Cancer Institute awarded a Project Grant of $495,715 to the Sloan-Kettering Institute for Cancer Research under the Cancer Biology Research program (CFDA 93.396) on August 5, 2025, with a completion date of July 31, 2030. This award funds fundamental research to decipher the pathogenesis and therapeutic vulnerabilities in germline RUNX1-mutated acute myeloid leukemia (AML). The research focuses on understanding how germline RUNX1 mutations...
- Federal Project Grant Award Summary The National Cancer Institute (NCI), under its Cancer Research Manpower program (CFDA 93.398), awarded $162,305.00 to the University of Michigan to support mentored research career development in cancer biology. Awarded on August 1, 2025, with a project period extending through July 31, 2030, this grant funds a K08 mentored research career development award for Dr. Peggy Hsu, MD, PhD. The project supports comprehensive investigation into early-stage Anaplastic...